A Multicenter, Open-label Uncontrolled Study to Investigate the Efficacy and Safety of a 4-phasic Oral Contraceptive SH T0065 in a 28-day Regimen for 13 Cycles in Healthy Female Subjects.
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2013
At a glance
- Drugs Estradiol valerate/dienogest (Primary)
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- 04 Dec 2005 New trial record.